富含植物性大麻素的局部用制剂:提取和稳定性测试
Dominika Kaczorová1,2,3, Jaroslav Peč4, Tibor Béres1
1Czech Advanced Technology and Research Institute, Palacký University, Olomouc, Czechia.
Frontiers in pharmacology
|August 18, 2023
概括
这项研究开发了一种快速,标准化的协议,用于准备医用大麻局部配方. 橄油和辛德曼基显示出高大麻素提取和稳定性,解决了皮肤病学使用的关键障碍.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 盖伦尼克药房 盖伦尼克药房
背景情况:
- 捷克医学大麻合法化 (2013) 允许用于皮肤疾病的局部治疗.
- 医用大麻性配方的有限实施归因于缺乏标准化的制备方案.
- 像大麻 (CBD) 和四大麻 (THC) 这样的大麻素显示出治疗潜在的疾病,包括亚托皮炎,牛皮和.
研究的目的:
- 评估各种制药基的大麻素提取能力.
- 为了评估皮肤病学用途的制备的基配方中的大麻素的稳定性.
- 为药房和医疗机构提出一个标准化,易于实施的准备协议.
主要方法:
- 评估了不同制药基因对大麻素的提取效率.
- 随着时间的推移,监测了基配方中的四大麻 (THC) 和大麻 (CBD) 的稳定性.
- 的物理和化学特性与大麻素的稳定性和提取相关.
主要成果:
- 配方中的大麻素稳定性取决于基的特性.
- 最高的THC分解发生在奶油基 (高达5.4%/周) 和瓦斯林 (高达5.6%/周).
- CBD表现出比THC更大的稳定性;橄油和辛德曼基表现出最高的提取率 (约. 70%) 和稳定性.
结论:
- 为医用大麻局部配方提出了一个快速且易于实施的准备协议.
- 橄油和辛德曼基被推用于皮肤学制剂的最佳大麻素提取和稳定性.
- 标准化协议对于医用大麻在皮肤疾病医疗保健中的更广泛实施至关重要.
关键词:
大麻树种L.大麻树种L.皮肤学 皮肤学提取物 提取物提取物素制剂的制备医用大麻医疗大麻的使用这是一种植物性大麻素 (phytocannabinoid).稳定的稳定性 稳定的稳定性局部应用 局部应用更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...


